Trial Profile
Study of Rever3mab in cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2016
Price :
$35
*
At a glance
- Drugs Rever3mab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 26 Jul 2016 New trial record